Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-30 @ 5:24 AM
Study NCT ID:
NCT01120457
Status:
COMPLETED
Last Update Posted:
2015-03-06
First Post:
2010-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08
Start Date Type:
None
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-07
First Submit QC Date:
None
Study First Post Date:
2010-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-05
Last Update Post Date:
2015-03-06
Last Update Post Date Type:
ESTIMATED